Search Results

New Science Study Results Reported from University of Vermont Larner College of Medicine (Identification of potent and orally efficacious phosphodiesterase inhibitors in Cryptosporidium parvum-infected immunocompromised male mice)

• Source: Obesity, Fitness & Wellness Week. October 19, 2024, 3853

Record details

Patent Application Titled 'Phosphodiesterase Inhibitors For The Mitigation Of Fragile X Syndrome Symptoms' Published Online (USPTO 20240285637)

• Source: Obesity, Fitness & Wellness Week. September 21, 2024, 686

Record details

Patent Issued for Tricyclic compounds and their use as phosphodiesterase inhibitors (USPTO 12049465)

• Source: Obesity, Fitness & Wellness Week. August 24, 2024, 1084

Record details

Data on Genitourinary Tract Agents Described by a Researcher at University Hospital [(201) Ophthalmological And Psychophysical Changes in Males Using Phosphodiesterase Inhibitors Type 5]

• Source: Hematology Week. December 30, 2024, 1491

Record details

Data from Lausanne University Hospital and University of Lausanne Provide New Insights into Biomedicine (Phosphodiesterase Inhibitors in Fetal Growth Restriction: Do Not Forget to Consider Fetal Sex and Subcellular Compartmentation)

• Source: Health & Medicine Week. November 1, 2024, 1332

Record details

Patent Issued for Phosphodiesterase inhibitors and uses thereof (USPTO 11851427)

• Source: Obesity, Fitness & Wellness Week. January 20, 2024, 1028

Record details

Identification of potent and orally efficacious phosphodiesterase inhibitors in Cryptosporidium parvum-infected immunocompromised mice

• Source: Obesity, Fitness & Wellness Week. October 14, 2023, 2529

Record details

New Findings Reported from Deraya University Describe Advances in Erectile Dysfunction [Proniosomal Gel-Loaded Phosphodiesterase Inhibitors (Sildenafil, Vardenafil, and Tadalafil): Prospects for Topical Penile Therapy of Tadalafil for Treatment ...]

• Source: Obesity, Fitness & Wellness Week. August 19, 2023, p3233

Record details

New Avenues for Phosphodiesterase Inhibitors in Asthma

• Authors : Matera, Maria Gabriella; Ora, Josuel; Cavalli, Francesco

• Source: Journal of Experimental Pharmacology. March 31, 2021, Vol. 13, p291, 12 p.

Record details

Researchers Submit Patent Application, 'Tricyclic Compounds And Their Use As Phosphodiesterase Inhibitors', for Approval (USPTO 20230146535)

• Source: Obesity, Fitness & Wellness Week. June 3, 2023, 1407

Record details